Genetic Variants of SARS-CoV-2—What Do They Mean?

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557

Spike mutation D614G alters SARS-CoV-2 fitness

Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,116

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint

Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313

We shouldn’t worry when a virus mutates during disease outbreaks

Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168

Diabetes Mellitus, a Leading Comorbidity in COVID-19: an Insight on Pathophysiology, Molecular Interactions, and Comprehensive Management

Panja, A., Manna, S., Chatterjee, M., Ghosh, T., Bid, S., & Choudhury, S. M. (2025) · Current Microbiology · doi:10.1007/s00284-025-04369-w · Cited by 3

Peptide nucleic acid biosensors: Structure–interface interactions, electrochemical signal strategies, and diagnostic applications

Kim, Y., & Mohanty, S. K. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250127 · Cited by 3

A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023

Oh, D., Hölzer, M., Börnigen, D., Paraskevopoulou, S., Duwe, S. C., Budt, M., Kerber, R., Mikołajewska, A., Böttcher, S., Seifried, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01093-1 · Cited by 4

The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions

McVoy, M. A., & Kummarapurugu, A. B. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70721 · Cited by 3

Exploring potential phytocompounds from black cumin as drug molecules against SARS-CoV-2 infections through bioinformatics analysis

Ali, M. A., Sheikh, H., Reza, M. S., Paul, T. R., Noor, T., Kumar, N., Bhat, M. A., & Mollah, M. N. H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0337970 · Cited by 3

Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States

Lin, S., Liu, H., Qi, Q., Ryan, I., Gao, D., Friedman, S., Xue, X. R., & Lawrence, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1419886 · Cited by 3

Frontliners on the Move: A Quantitative Analysis of the Prevalence of COVID-19 Reinfection Among Healthcare Workers

Kurra, N., Sriram, K., Gandrakota, N., Nagarajan, J. S., Khasnavis, S., Ramakrishnan, M., Dalal, S., Irfan, S. A., Khan, S. N., Jk, H., et al. (2022) · Cureus · doi:10.7759/cureus.24652 · Cited by 3

Characterizing the Severity of SARS-CoV-2 Variants at a Single Pediatric Center

Khan, A., Ichura, C., Wang, H., de Rezende, I. M., Sahoo, M. K., Huang, C., Solis, D., Sibai, M., Yamamoto, F. F., Nyathi, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.896352 · Cited by 3

Efficacy of Online Mental Health Program “EmoAid” during the COVID-19 Pandemic

Gupta, S., Gupta, D., Goel, E., & Rehman, U. (2022) · Journal of Mental Health and Human Behaviour · doi:10.4103/jmhhb.jmhhb_252_21 · Cited by 3

The evaluation of an automated mariPOC SARS‐CoV‐2 antigen test compared to RT‐qPCR SARS‐CoV‐2 assay and comparison of its sensitivity in Delta‐ and Omicron‐variant samples

Krůtová, M., Brajerova, M., Kepka, Z., Briksí, A., Hubáček, P., & Dřevı́nek, P. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13048 · Cited by 3

Emergence of COVID-19 Variants and Its Global Impact

Kunal, S., Ish, P., Aditi, & Gupta, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_9 · Cited by 3

Evolution of differences in clinical presentation across epidemic waves among patients with COVID-like-symptoms who received care at the Mexican Social Security Institute

Oláiz, G., Bertozzi, S., Juárez-Flores, A., Borja‐Aburto, V. H., Anda, F. J. V.-D., Ascencio-Montiel, I. D. J., & Gutiérrez, J. P. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1102498 · Cited by 3

Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave

Belayachi, J., Mhayi, A., Majidi, H., Fahime, E. E., & Abouqal, R. (2024) · Vaccines · doi:10.3390/vaccines12030244 · Cited by 3

Genetic Variants of SARS-CoV-2: What Do We Know So Far?

Jamil, S. M., Shafazand, S., Pasnick, S., Carlos, W. G., Maves, R. C., & Cruz, C. S. D. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2021c5 · Cited by 3

Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America

Jian, M., Chung, H., Chang, C.-K., Hsieh, S., Lin, J., Yeh, K., Chen, C., Chang, F., Hung, K., Liu, M., et al. (2021) · PeerJ · doi:10.7717/peerj.11991 · Cited by 3

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece

Halvatsiotis, P., Vassiliu, S., Koulouvaris, P., Chatzantonaki, K., Asonitis, K., Charvalos, E., Siatelis, A., & Houhoula, D. P. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44010024 · Cited by 3

Variantes del Sars-Cov-2: características genómicas

Lucero, P. A. F., Martínez, J. A. N., Ypanaque, S. A. M., & Arellano, D. A. A. G. (2022) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v6i1.1608 · Cited by 3

Diversity due to mutations in circulating virus strains of SARS-CoV-2 may delay control of COVID-19

Patil Sharanagouda, S., Shivamallu, C., Dharmashekara, C., Sushma, P., Puttahonnappa, S. K., Ashwini, P., Prasad, K. S., Yadav Mahendra, P., Chandrashekar, S., & Bramhadev, P. (2022) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2022.100223 · Cited by 3

Fighting Pandemics with Physical Distancing Management Technologies

Storey, V. C., Lukyanenko, R., & Grangé, C. (2022) · Journal of Database Management · doi:10.4018/jdm.305731 · Cited by 3

An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination

Chowdhury, P., Bhattacharya, S., Gogoi, B., Veeranna, R. P., & Kumar, S. (2022) · Vaccines · doi:10.3390/vaccines10101639 · Cited by 3

Prevalence of SARS-CoV-2 Variants in COVID-19 Positive Patients

Aydoğan, O., Şaylan, E. G., Güven, Ö., Ayaz, A., & Yiğitbaşı, T. (2022) · Klimik Dergisi/Klimik Journal · doi:10.36519/kd.2022.4264 · Cited by 3

Evaluation of Four Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection with Nasopharyngeal Swabs

Lim, H. J., Park, M., Baek, Y.-H., Lee, H.-S., Kim, I., Kwon, Y., You, Y., Nam, K., Yang, J.-H., Kim, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030701 · Cited by 3

Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model

Baek, K., Kim, D., Kim, J.-S., Kang, B. M., Park, H., Park, S., Shin, H.-E., Lee, M.-H., Maharjan, S., Kim, M., et al. (2024) · Virus Genes · doi:10.1007/s11262-024-02067-6 · Cited by 3

Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial

Heng, F., Sun, Y., Li, L., & Gilbert, P. B. (2025) · Statistics in Medicine · doi:10.1002/sim.10345 · Cited by 3

New SARS‐CoV‐2 variant of concern imported from the United Kingdom to Vietnam, December 2020

Manh, D. H., Nguyen, H. T., Nguyen, T. V., Nguyen, A. H., Lương, Q. C., Vu, N. H. P., Pham, H., Nguyen, T. N. T., Thach, D. H., Nguyen, L. V., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26908 · Cited by 3

What is Currently Known About the SARS-CoV2 Variants of Concern

Souaid, T., Hindy, J.-R., & Kanj, S. S. (2021) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.210605.001 · Cited by 3

A cross-sectional study of COVID-19 outbreak in Indian population

Arumugam, M., Najimudeen, R. B. H., Vijayan, A., Sathyamoorthy, B., & Patole, P. S. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103554 · Cited by 3

SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing

Martı́nez-Murcia, A., García-Sirera, A., Navarro, A., & Pérez, L. (2022) · Viruses · doi:10.3390/v14112588 · Cited by 3

Population (Antibody) Testing for COVID-19—Technical Challenges, Application and Relevance, an English Perspective

Maple, P. A. C. (2021) · Vaccines · doi:10.3390/vaccines9060550 · Cited by 3

In vitro and computational analysis of the putative furin cleavage site (RRARS) in the divergent spike protein of the rodent coronavirus AcCoV-JC34 (sub-genus luchacovirus)Preprint

Choi, A., Singleton, D. T., Stout, A. E., Millet, J. K., & Whittaker, G. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.473025 · Cited by 3

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersPreprint

Bruno, R., McCullough, P. A., Vila, T. F. I., Henrion‐Caude, A., García-Gasca, T., Zaitzeva, G. P., Priester, S., Albarracín, M. J. M., Sousa‐Escandón, A., Mirones, F. L., et al. (2021) · doi:10.22541/au.162136772.22862058/v1 · Cited by 3

Immunogenicity of two‐dose sinopharm BBIB‐CorV vaccine in Morocco: One‐year follow‐up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern

Ouarab, M., Bouaiti, E., Rhazzar, Z., Annaz, H. E., Kochri, S. E., Hemlali, M., Ghammaz, H., Nyabi, O., Bakkouri, K. E., Touil, N., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1359 · Cited by 2

Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq

Al-Mankhee, A. A., Moatasim, Y., Taweel, A. E., Gomaa, M. R., Alfarouk, O. R., Gado, M. M., Barakat, A., Ali, M. A., & El‐Shesheny, R. (2024) · Pathogens · doi:10.3390/pathogens13121051 · Cited by 2

Evolutionary Insight into Fatal Human Coronaviruses (hCoVs) with a Focus on Circulating SARS-CoV-2 Variants Under Monitoring (VUMs)

Izhari, M. A., Alghamdi, F., Alodeani, E. A., Salem, A., Almontasheri, A. H. A., Dardari, D. M. M., Hadadi, M. A. A., Gosady, A. R. A., Alghamdi, W. A., Alzahrani, B. A., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13102450 · Cited by 2

StealthX: A Versatile and Potent Exosome-Based Vaccine Platform for the Next Pandemic

Sun, M., & Elliott, K. (2025) · Vaccines · doi:10.3390/vaccines13121239 · Cited by 2

Alpha to Omicron (Variants of Concern): Mutation Journey, Vaccines, and Therapy

Hamad, M., AlKhamach, D. M. H., Alsayadi, L. M., Sarhan, S. A., Saeed, B. Q., Sokóvić, M., Hadda, T. B., & Soliman, S. S. M. (2023) · Viral Immunology · doi:10.1089/vim.2022.0122 · Cited by 2

Bioethical and Human Right Considerations during COVID-19 Pandemic Period: Reflections of Integrated Oncology Clinical Services from India

Madathil, L. P., Palatty, P. L., Sacheendran, D., Jayachander, M., George, T., Gur, A., Krishna, A., D’Souza, R. F., & Baliga, M. S. (2024) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0043-1774779 · Cited by 2

Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves.

Esperatti, M., Olmos, M., Busico, M., Gallardo, A., Vitali, A., Quintana, J., Kakisu, H., Ferreyro, B. L., Fuentes, N. A., Osatnik, J., et al. (2024) · PubMed Central · doi:10.62675/2965-2774.20240065-en · Cited by 2

Perceived quarantine competence, attitudes and practices among the public during the coronavirus pandemic: A Saudi descriptive study

Almarwani, A. M., Aljohani, M., & Eweda, G. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14242 · Cited by 2

COVID-19 and Emerging Zoonosis - The Clock is Counting Down: Time for Closer Collaboration between Veterinary and Human Medicine

Coelho, A. C. (2021) · Open Access Journal of Veterinary Science & Research · doi:10.23880/oajvsr-16000209 · Cited by 2

Is Gain of Function a Reliable Tool for Establishing Sars-Cov-2 Origin?

Guardo, G. D. (2022) · Advances in Microbiology · doi:10.4236/aim.2022.123009 · Cited by 2

Ligation‐based assay for variant typing without sequencing: Application to SARS‐CoV‐2 variants of concern

Nelson, D. J., Shilts, M. H., Pakala, S., Das, S. R., Schmitz, J. E., & Haselton, F. R. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13083 · Cited by 2

Coronavirus disease 2019 and pediatric anesthesia

Tan, J. M., Disma, N. M., & Matava, C. T. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001000 · Cited by 2

Epitope-based Multi-variant SARS-Cov-2 Vaccine Design: Shared Epitopes Among the Natural SARS-Cov-2 Spike Glycoprotein and 5 of its Variants (D614G, α, β, γ, δ) with High in Silico Binding Affinity to Human Leukocyte Antigen (HLA) Class II Molecules

Charonis, S. A., & Georgopoulos, A. P. (2021) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2021/4.1223 · Cited by 2

Genomic surveillance identifies potential risk factors for SARS-CoV-2 transmission at a mid-sized university in a small rural town

Andrews, K. R., New, D. D., Gour, D. S., Francetich, K., Minnich, S. A., Robison, B. D., & Hovde, C. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-34625-7 · Cited by 2

The Opportunity of Data-Driven Services for Viral Genomic Surveillance

Bernasconi, A. (2023) · IEEE International Symposium on Service-Oriented System Engineering (SOSE) · doi:10.1109/sose58276.2023.00028 · Cited by 2

Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase

Boon, W. X., Sia, B. Z., & Ng, C. H. (2024) · F1000Research · doi:10.12688/f1000research.72896.4 · Cited by 2

INFLUENCE OF COVID-19 AND VACCINATION AGAINST SARS-COV-2 ON THE COURSE OF ONCOHEMATOLOGICAL DISEASES. PART I. GENETIC CHARACTERISTICS OF SARS-COV-2 VARIANTS UPON THE THREE WAVES OF THE PANDEMIC IN UKRAINE

Kovalevska, L. M., Щербіна, В. М., Kryachok, I., Matveeva, A. S., & Кашуба, О. В. (2024) · Oncology · doi:10.15407/oncology.2024.03.216 · Cited by 2

Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis

Nasker, S. S., Nanda, A., Ramadass, B., & Nayak, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111203 · Cited by 2

The pediatric asymptomatic SARS-CoV-2 IgG seropositivity in the Turkish Republic of Northern Cyprus

Gazi, U., Sayan, M., Çakır, N., Süer, K., Beyitler, İ., Dalkan, C., Şanlıdağ, B., Ruh, E., Sarıoğlu, A. A., & Şanlıdağ, T. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2021.1330 · Cited by 2

Long-read sequencing of SARS-CoV-2 reveals novel transcripts and a diverse complex transcriptome landscapePreprint

Li‐Pook‐Than, J., Banuelos, S., Honkala, A. T., Sahoo, M. K., Pinsky, B. A., & Snyder, M. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.434150 · Cited by 2

Analysis of Current Status and Simulations of Future Spread of COVID-19 in the United StatesPreprint

Liu, X., & DeVries, A. (2021) · Research Square · doi:10.21203/rs.3.rs-310822/v1 · Cited by 2

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersPreprint

Bruno, R., McCullough, P. A., Vila, T. F. I., Henrion‐Caude, A., García-Gasca, T., Zaitzeva, G. P., Priester, S., Albarracín, M. J. M., Sousa‐Escandón, A., Mirones, F. L., et al. (2021) · doi:10.22541/au.162136772.22862058/v2 · Cited by 2

Screening for the alpha variant of SARS-CoV-2 (B.1.1.7) the impact of this variant on circulating biomarkers in hospitalised patientsPreprint

Braybrook, E., Pandey, S., Vryonis, E., Anderson, N. R., Young, L. S., & Grammatopoulos, D. K. (2021) · medRxiv · doi:10.1101/2021.06.18.21258699 · Cited by 2

Phylogenetic network analysis revealed the recombinant origin of the SARS-CoV-2 VOC202012/01 (B.1.1.7) variant first discovered in U.K.Preprint

Xie, X., Lewis, T.-J., Green, N., & Wang, Z. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.24.449840 · Cited by 2

The COVID-19 variants: an overview

Pandey, A. K., Mishra, S. S., Wadgave, Y., Mudgil, N., Gawande, S., & Dhange, V. B. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20213826 · Cited by 2

How Far Could these New SARS-CoV-2 Variants Take Us?

Carneiro, F. A., & Caldas, L. A. (2021) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2021.04.0853 · Cited by 1

The COVID-19 Pandemic in South Asia: A Comprehensive Review of the Genomic Variations, Epidemiological Features, Diagnosis, Treatment and Preventive Schemes

Noman, A. A., Ekra, J. E., Meem, R. I., Islam, S., Sharzana, F., Islam, S., Sana, S., Mahmud, N., Kabir, M., Mahedi, A. A., et al. (2022) · Journal of Health Research · doi:10.56808/2586-940x.1018 · Cited by 1

Potential use of high-resolution melting analyses for SARS-CoV-2 genomic surveillance

Andrade, A. D. S., Freitas, E. F., Barbosa, E. D. C., Guimarães, N. R., Iani, F. C. D. M., da Costa, A. V. B., Bernardes, A. F. L., Adelino, T., Ataide, A. C. Z., Gregianini, T. S., et al. (2023) · Journal of Virological Methods · doi:10.1016/j.jviromet.2023.114742 · Cited by 1

Molecular Epidemiology of SARS-CoV-2 Variants in Vaccinated and Non-Vaccinated Patients of Erbil Province, Kurdistan Region-Iraq

Hassan, D. A., Maulud, S. Q., Rashid, R. F., Ahmed, J. Q., & Ali, R. K. (2024) · BioMed Target Journal · doi:10.59786/bmtj.213 · Cited by 1

Reconstructing early transmission networks of SARS-CoV-2 using a genomic mutation model

Cheng, C.-Y., 中国科学院动物研究所农业虫害鼠害综合治理研究国家重点实验室, 北. 1., Zhang, Z.-B., & 中国科学院生物互作卓越创新中心, 北. 1. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.535 · Cited by 1

SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies

Napolitano, J. M., Srikanth, S., Noorai, R. E., Wilson, S., Williams, K. E., Rosales-García, R. A., Krueger, B. J., Emerson, C. E., Parker, S., Pruitt, J., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301225 · Cited by 1

Evolving fitness and immune escape: a retrospective analysis of SARS-CoV-2 spike protein (2020-2024) using protein language model

Peng, S., Lyu, L., Registre, L., Subedi, S., Mubassir, M. H. M., Bakheet, M., & Bahl, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1576414 · Cited by 1

Phylogenetic analysis of the SARS-CoV-2 spike (S) glycoprotein sequence implicates small mammals and wastewater as potential sources of infection

Edet, U. O., Ali, M. Z., Igah, O. E., & Meseko, C. A. (2026) · German Journal of Microbiology · doi:10.51585/gjm.2026.1.0057 · Cited by 1

Inducing Quality Immune Response to Respiratory Viruses May Not Be a Simple Task

Ranga, U., & Asokan, M. (2021) · Current Science · doi:10.18520/cs/v120/i8/1315-1323 · Cited by 1

Spatial Epidemiology of COVID-19 Pandemic: Disease Risk, Prognosis, and Complications

Ssentongo, P., Fronterrè, C., & Chinchilli, V. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_11 · Cited by 1

Is the Authoritative Online COVID-19 Consumer Health Information Intelligible to Adults of the General Public?: A COVID-19 Information Analysis

Tu-Keefner, F., Hobbs, A., & Bricker, A. (2022) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2022.2124493 · Cited by 1

Features of the epidemic process in the spread of a new coronavirus infection COVID-19 on the territory of the metropolitan area in the period 2020–2022

Olenkova, О. М., Kovtun, O. P., Beikin, Y. B., Кузнецова, Е. А., Tikhomirova, A. A., & Cheremokhina, T. S. (2023) · Ural Medical Journal · doi:10.52420/2071-5943-2023-22-5-33-41 · Cited by 1

Modeling the SARS-CoV-2 sublineages XBB and BQ.1 in Mexico, considering multiple vaccinations, booster dose, waning immunity and cross-immunity

de León, U. A.-P., Pérez, Á. G. C., & Avila-Vales, E. J. (2024) · Electronic Research Archive · doi:10.3934/era.2024053 · Cited by 1

Molecular Study of SARS-CoV-2 Variants in Iranian Patients: A Multi-Center Study

Niya, M. H. K., Tabibzadeh, A., Yazdani, S., Hormati, A., Keshavarz, M., Ghasroldasht, M. M., Khodadadi, J., Vaez, A., Seif, F., & Mohebbi, E. (2023) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-138090 · Cited by 1

Inmunidad y vacunación contra la covid-19

Anaya, J., González, J. M., Villalba-Vizcaíno, V., Grajales, P. J. P., Rengifo, C., Trillos, C., & Gamboa, L. F. (2021) · Medicina · doi:10.56050/01205498.1558 · Cited by 1

Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant

Maclot, F., Bontems, S., Meex, C., Artesi, M., Beckers, P., Bours, V., Durkin, K., & Hayette, M. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.035 · Cited by 1

A'dan Z'ye COVID-19

Toptan, H., Şahin, E. Ö., Aydemir, Ö., Sunar, İ., Nas, K., Karacaer, C., Güneysu, F., Aydemir, Y., Kocayiğit, İ., Acar, T., et al. (2021) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.9 · Cited by 1

Treatment Approach, Pharmacological Agents and Vaccines

Tafoya, Q. J., Watson, V., Pawloski, J., Mohamed, G., & Ramadan, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-82691-4.00015-7 · Cited by 1

Fájdalomtünetek és a fájdalomcsillapítás lehetőségei SARS-CoV-2-környezetben

Almási, R. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32259 · Cited by 1

Vaccines against COVID-19 – Catching the Rays of Hope

Srinivasamurthy, S. K., & Bairy, L. K. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i47a33035 · Cited by 1

Exploring the effectiveness of a P4P scheme from the perspective of Italian general practitioners: A replication study

Giancotti, M., Mauro, M., & Rania, F. (2022) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3417 · Cited by 1

Critical Mutations of the SARS-CoV-2 Virus

Scott, R., & Fernández, A. (2022) · WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE · doi:10.37394/23208.2022.19.4 · Cited by 1

Development of PCR test for detection of the SARS-CoV-2 genetic variants alpha, beta, gamma, delta

Shipulin, G. A., Savochkina, Y. A., Константиновна, Ш. А., Shivlyagina, E., Nosova, A. O., Евгеньевна, Д. Е., Luparev, A. R., Владимировна, М. Т., & Yudin, S. M. (2022) · Medicine of Extreme Situations · doi:10.47183/mes.2022.003 · Cited by 1

COVID19, ENVIRONMENT, CLINICOPATHOLOGIC FEATURES, LABORATORY FINDINGS AND DIAGNOSIS, TREATMENT, VACCINES, ANIMALS, AND CANCER

Namagerdi, A. A., Ciani, F., d’Angelo, D., Napolitano, F., & Avallone, L. (2022) · Annals of Research in Oncology · doi:10.48286/aro.2022.40 · Cited by 1

Omicron variant and change of electrostatic interactions between receptor binding domain of severe acute respiratory syndrome coronavirus 2 with the angiotensin-converting enzyme 2 receptor

Mungmunpuntipantip, R., & Wiwanitkit, V. (2022) · World Journal of Virology · doi:10.5501/wjv.v11.i3.144 · Cited by 1

A simulation of geographic distribution for the emergence of consequential SARS-CoV-2 variant lineages

Akaishi, T., & Ishii, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-14308-5 · Cited by 1

Landscape Determinants of Infectivity and Insights into Vaccine Development and Effectiveness - Novel Coronavirus

Hasan, S., Dwivedi, M., Mukhopadhyay, S., & Gupta, N. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220628105636 · Cited by 1

A Case Series of SARS-CoV-2 Reinfection in Elite Athletes

Fülöp, G., Lakatos, B., Ruppert, M., Kovács, A., Juhász, V., Dér, G., Tállay, A., Vágó, H., Kiss, B., Merkely, B., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113798 · Cited by 1

SARS-CoV-2 Lineage P.4 Detection in Southeast Brazil: A Retrospective Genomic and Clinical Overview

Poleti, M., Lesbon, J. C. C., Mattos, E. C., Patané, J. S. L., Clemente, L. G., Viala, V. L., Ribeiro, G. D. C., Pinheiro, J. F. P., Giovanetti, M., Alcantara, L. C. J., et al. (2022) · COVID · doi:10.3390/covid2120127 · Cited by 1

LE VIRUS SARS-COV-2 ET SES VARIANTS

MONETTI, M., Pozzetto, B., PLOTTON, C., & GOCKO, X. (2021) · EXERCER · doi:10.56746/exercer.2021.171.118 · Cited by 1

Point-of-Care Testing of COVID-19: Current Status, Clinical Impact, and Future Therapeutic Perspectives

Gangula, A., Kim, B., Casey, B., Hamill, A., Regunath, H., & Upendran, A. (2022) · SpringerBriefs in applied sciences and technology · doi:10.1007/978-981-19-4957-9_1 · Cited by 1

First Steps towards Efficient Genome Assembly on ARM-Based HPC

Poje, K., Brčić, M., Knezović, J., & Kovač, M. (2023) · Electronics · doi:10.3390/electronics13010039 · Cited by 1

Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls

Németh, D., Vágó, H., Tóthfalusi, L., Ulakcsai, Z., Becker, D. A., Szabo, Z., Rojkovich, B., Gunkl-Tóth, L., Merkely, B. P., & Nagy, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397052 · Cited by 1

Construction of a potent pan-vaccine based on the evolutionary tendency of SARS-CoV-2 spike proteinPreprint

Zhao, Y., Ni, W., Liang, S., Dong, L., Xiang, M., Cai, Z., Niu, D., Zhang, Q., Wang, D., Zheng, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.21.473594 · Cited by 1

Genomic surveillance reveals the emergence of SARS-CoV-2 Lineage A from Islamabad PakistanPreprint

Umair, M., Ikram, A., Rehman, Z., Haider, S. A., Badar, N., Ammar, M., Ali, Q., Ahad, A., Suleman, R., & Salman, M. (2021) · medRxiv · doi:10.1101/2021.12.24.21268367 · Cited by 1

Lessons from the self-terminating COVID-19 pandemic: Vaccination, vitamin A deficiency and a brief epidemiological viewPreprint

Sarohan, A. R. (2022) · doi:10.31219/osf.io/rzbdf · Cited by 1

A flexible and high-throughput genotyping workflow tracked the emergence of SARS-CoV-2 variants in the UK in 2022Preprint

Lee, S., Grujic, S., Modern, S., Wann, A., Fraser, D. P., & Percival, B. C. (2023) · medRxiv · doi:10.1101/2023.06.03.23289684 · Cited by 1

COVID-19 Delta variant in Canada: FAQ on origins, hotspots and vaccine protection

Kindrachuk, J., & Shaw, S. Y. (2021) · doi:10.64628/aam.hppnjvjke · Cited by 1

Evolution of differences in clinical presentation across epidemic waves among suspected COVID-19 cases who received care at the Mexican Social Security Institute (IMSS)Preprint

Olaiz, G., Bertozzi, S. M., Juárez-Flores, A., Borja‐Aburto, V. H., Vicuña, F., Ascencio-Montiel, I. J., & Gutierrez, J. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1879100/v1 · Cited by 1

Commentary on “COVID-19 pneumonia in the emergency department: correlation of initial chest CT findings with short-term outcome”

Barbosa, C. S., & Lee, H. J. (2021) · Journal of Lung Health and Diseases · doi:10.29245/2689-999x/2021/1.1167

Covid-19 in familial cluster: ultrashort incubation period could be an early indication of Brazilian Variant of SARS-Cov-2 virus?

Oliveira, G. A., & Oliveira, G. M. L. (2021) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e6726.2021

A Prospective Study to Evaluate the Clinical Performance of A Novel MultitargetBased Antigen Test on the Detection of SARS-CoV-2 in Symptomatic PopulationComparison to Nuclear Acid-Based Tests

Wang, Y., Rao, E., Wan, D. D., Patterson, C., Wan, D. D., Pogosyan, A., Wan, J., & Rao, J. (2021) · Journal of Epidemiology and Public Health Reviews · doi:10.16966/2471-8211.211

Coronavirus-2019: Origin and evolution

Mandal, N. C. (2021) · Journal of Hematology and Allied Sciences · doi:10.25259/jhas_8_2021

The significance and impact of SARS‐CoV‐2 variants of concern in pediatric solid organ transplantation: More unknowns than knowns

Groves, H. E., Piché‐Renaud, P., & Allen, U. (2021) · Pediatric Transplantation · doi:10.1111/petr.14071

Genetic variants of SARS-CoV-2 and its clinical implications

Lara, A. E., Díaz, G. E. F., Benítez, S. N. G., & Soca, P. E. M. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS

Korsun, N., Trifonova, I. T., Dobrinov, V., Grigorova, I., Angelova, S. G., & Alexiev, I. (2022) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/pipd.v49i3.73

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?

Ergören, M. Ç., Tulay, P., & Dündar, M. (2021) · The EuroBiotech Journal · doi:10.2478/ebtj-2021-0001 · Cited by 2

Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance

Dholariya, S. J., Parchwani, D. N., Singh, R., Sonagra, A. D., Motiani, A., & Patel, D. D. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00991-0 · Cited by 13

COVID Mutation and Effect on Vaccine

Tian, Z. (2022) · Applied economics and policy studies · doi:10.1007/978-981-19-0564-3_5